Cite
HARVARD Citation
Rapoport, B. et al. (2009). Phase II Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-Sensitive and Partially Platinum-Sensitive Metastatic Ovarian Cancer. International journal of gynecological cancer. 19 (6), pp. 1137-1141. [Online].